Stem Call treatment

Stem cells therapies represent a new field of biomedical science which could provide in the future the cure for diseases until now incurable. Many gastrointestinal diseases are a major reason for the increased mortality rate of children and adults every year. However, intestinal transplantation is still accompanied by many challenges, including immune rejection and donor availability, which may limit the transplant's success. The development of more safe and promising alternative treatments for intestinal diseases is still ongoing. Stem cell-based therapy (SCT) and tissue engineering (TE) appear to be the next promising choices for the regeneration of the damaged intestine. However, suitable stem cell source is required for the SCT and TE process. Thus, in this review we discuss how intestinal stem cells (ISCs) are a promising cell source for small intestine diseases.

Here, we report on the issues discussed, including liver and intestinal diseases that may benefit from stem cell therapy, the biology of hepatic and intestinal tissue repair, and stem cell usage in clinical trials.



 


    Related Conference of Stem Call treatment

    August 27-28, 2025

    13th World Gastro Summit

    Paris, France
    May 21-22, 2026

    17th International Conference on Liver Diseases & Hepatology

    Aix-en-Provence, France
    June 18-19, 2026

    9th International Congress on Viral Hepatitis

    Paris, France
    June 29-30, 2026

    5th International Conference on Gastroenterology and Liver

    Aix-en-Provence, France
    August 03-04, 2026

    21st Euro-Global Gastroenterology Conference

    London, UK
    September 29-30, 2026

    7th Global Summit on Earth Science and Climate Change

    Aix-en-Provence, France

    Stem Call treatment Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in